Articles
Alemtuzumab (CAMPATH) not yet approved for MS
- Details
- Category: Medications
- Written by R. Adam Quigley
- Hits: 2297
* immunosuppressive medication - powerful
* rarely used as therapy at first due to their increased risk
* risk of automimmune complications
* bleeding (ITP) in 2-3 %
* thyroid dysfunction in about 20%
* appears more powerful than interferon-beta
